Novo Nordisk will sell a less expensive one-month supply of Wegovy for patients who previously took compounded versions of ...

Evernorth has capped antiobesity drug monthly co-pays at $200 in a move to improve access and affordability amid new drug ...

Researchers are beginning to wonder whether blockbuster drugs such as Wegovy, Ozempic and Zepbound could play a role in ...

As demand for GLP-1 weight-loss medications like Wegovy and Zepbound continues to grow in the United States, so do questions about their affordability.

New research has found that GLP-1 drugs can substantially reduce the risk of obesity-related cancers — and they’re more ...

Orlistat (sold as Alli) is one effective over-the-counter weight loss aid that is also FDA-approved.

Researchers found GLP-1s may modestly reduce the risk of 14 obesity-related cancers, especially colorectal cancer, when compared to a weight-neutral medication used to treat diabetes.

Report from Canada’s Drug Agency says Wegovy cuts risk of heart attack, stroke or cardiovascular death by 20 per cent ...

Patients who stop using weight loss medications are likely to return to their baseline weight within two years, a new ...

In study after study, injected GLP-1 weight loss medications appear to work better on average for women than they do for men.

ABC News chief medical correspondent Dr. Tara Narula explains the findings of a new study on GLP-1 drugs commonly used for weight loss. Dr. Alexandra Sowa, an obesity medicine specialist and autho ...

Popular obesity and diabetes drugs called GLP-1 medications may have added benefits, with a new study finding they helped ...